Know Cancer

or
forgot password

Effects of Magnesium Sulphate on the Pharmacodynamics of Rocuronium in Patients 60 Years or Older: Randomised and Double-Blind Study


Phase 1
60 Years
N/A
Not Enrolling
Both
Head and Neck Cancer

Thank you

Trial Information

Effects of Magnesium Sulphate on the Pharmacodynamics of Rocuronium in Patients 60 Years or Older: Randomised and Double-Blind Study


Inclusion Criteria:



- 60 years or older

- ASA physical status I-III

- Scheduled for elective oncologic head and neck surgery

Exclusion Criteria:

- Severe renal insufficiency (calculated creatinine clearance < 30 ml/min)

- Pre-operatory serum magnesium values > 2.5 mEq/l

- Patients receiving medications known to affect neuromuscular function (furosemide,
aminoglycoside, anticonvulsivants, calcio channel blocker, litium, azatioprine,
cyclofosfamide)

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Supportive Care

Outcome Measure:

Total recovery time of neuromuscular block (DurTOF0.9)

Outcome Description:

Time from the start of injection of rocuronium until TOF ratio 0.9

Outcome Time Frame:

Within the surgical procedure

Safety Issue:

No

Principal Investigator

Pedro Rotava, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Instituto Nacional de Cancer

Authority:

Brazil: Ministry of Health

Study ID:

MgRoc 60

NCT ID:

NCT01804205

Start Date:

September 2008

Completion Date:

March 2012

Related Keywords:

  • Head and Neck Cancer
  • magnesium sulfate
  • rocuronium
  • neuromuscular block
  • onset time
  • elderly
  • Head and Neck Neoplasms

Name

Location